Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 970 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib Impurity 76 REF: 4Z-C-121079CAS: 868540-16-3	- - -	To inquire	Mon 10 Mar 25
Palbociclib Impurity 57 REF: 4Z-P-196064	- - -	To inquire	Mon 10 Mar 25
Olaparib Impurity 40 REF: 4Z-O-032045CAS: 2268028-68-6	- - -	To inquire	Mon 10 Mar 25
Nintedanib N-Glucuronide-1 (Intedanib N-Glucuronide) REF: 4Z-N-066022	- - -	To inquire	Mon 10 Mar 25
Olaparib Impurity 61 REF: 4Z-O-032066CAS: 59878-57-8	- - -	To inquire	Mon 10 Mar 25
Enzalutamide Impurity 40 REF: 4Z-E-068053CAS: 1895865-11-8	- - -	To inquire	Mon 10 Mar 25
Olaparib REF: TM-T3015CAS: 763113-22-0	100% - 99.90%	37.00 €~235.00 €	Mon 10 Mar 25
Fulvestrant Enantiomer REF: 4Z-F-3139	- - -	To inquire	Mon 10 Mar 25
Nintedanib Impurity 34 REF: 4Z-N-066051CAS: 2036139-30-5	- - -	To inquire	Mon 10 Mar 25
Nintedanib Impurity 20 REF: 4Z-N-066034CAS: 1912-28-3	- - -	To inquire	Mon 10 Mar 25
N1, N2-Di-Nitroso Palbociclib REF: 4Z-P-196083	- - -	To inquire	Mon 10 Mar 25
Palbociclib Impurity 60 REF: 4Z-P-196067CAS: 2488840-59-9	- - -	To inquire	Mon 10 Mar 25
Olaparib Impurity 36 REF: 4Z-O-032041	- - -	To inquire	Mon 10 Mar 25
Goserelin EP Impurity C REF: 4Z-PG-1510	- - -	To inquire	Mon 10 Mar 25
Abiraterone Impurity 17 REF: 4Z-A-8255CAS: 154229-21-7	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 28 REF: 4Z-C-121031CAS: 143415-51-4	- - -	To inquire	Mon 10 Mar 25
Gimeracil Impurity 2 REF: 4Z-G-047002	- - -	To inquire	Mon 10 Mar 25
Olaparib Impurity 4 REF: 4Z-O-032006CAS: 1021298-68-9	- - -	To inquire	Mon 10 Mar 25
Lenvatinib-d5 REF: 4Z-L-124056	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 29 REF: 4Z-C-121032	- - -	To inquire	Mon 10 Mar 25

5mg		To inquire
10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

1g		235.00 €
5mg		37.00 €
10mg		52.00 €
50mg		74.00 €
100mg		89.00 €
200mg		118.00 €
500mg		170.00 €

Cancer treatment

Carfilzomib Impurity 76

Ref: 4Z-C-121079

Palbociclib Impurity 57

Ref: 4Z-P-196064

Olaparib Impurity 40

Ref: 4Z-O-032045

Nintedanib N-Glucuronide-1 (Intedanib N-Glucuronide)

Ref: 4Z-N-066022

Olaparib Impurity 61

Ref: 4Z-O-032066

Enzalutamide Impurity 40

Ref: 4Z-E-068053

Olaparib

Ref: TM-T3015

Fulvestrant Enantiomer

Ref: 4Z-F-3139

Nintedanib Impurity 34

Ref: 4Z-N-066051

Nintedanib Impurity 20

Ref: 4Z-N-066034

N1, N2-Di-Nitroso Palbociclib

Ref: 4Z-P-196083

Palbociclib Impurity 60

Ref: 4Z-P-196067

Olaparib Impurity 36

Ref: 4Z-O-032041

Goserelin EP Impurity C

Ref: 4Z-PG-1510

Abiraterone Impurity 17

Ref: 4Z-A-8255

Carfilzomib Impurity 28

Ref: 4Z-C-121031

Gimeracil Impurity 2

Ref: 4Z-G-047002

Olaparib Impurity 4

Ref: 4Z-O-032006

Lenvatinib-d5

Ref: 4Z-L-124056

Carfilzomib Impurity 29

Ref: 4Z-C-121032